Magadh Sugar & Energy Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2025, 9:49 pm

Competitors of Magadh Sugar & Energy Ltd

All Competitor Stocks of Magadh Sugar & Energy Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:30 am

Below is a detailed analysis of the quarterly data for Magadh Sugar & Energy Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 333.04 Cr.. The value appears to be declining and may need further review. It has decreased from 355.21 Cr. (Mar 2025) to 333.04 Cr., marking a decrease of 22.17 Cr..
• For Expenses, as of Jun 2025, the value is 313.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 239.81 Cr. (Mar 2025) to 313.96 Cr., marking an increase of 74.15 Cr..
• For Operating Profit, as of Jun 2025, the value is 19.08 Cr.. The value appears to be declining and may need further review. It has decreased from 115.40 Cr. (Mar 2025) to 19.08 Cr., marking a decrease of 96.32 Cr..
• For OPM %, as of Jun 2025, the value is 5.73%. The value appears to be declining and may need further review. It has decreased from 32.49% (Mar 2025) to 5.73%, marking a decrease of 26.76%.
• For Other Income, as of Jun 2025, the value is 0.84 Cr.. The value appears strong and on an upward trend. It has increased from 0.82 Cr. (Mar 2025) to 0.84 Cr., marking an increase of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 12.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.76 Cr. (Mar 2025) to 12.24 Cr., marking a decrease of 0.52 Cr..
• For Depreciation, as of Jun 2025, the value is 7.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.26 Cr. (Mar 2025) to 7.41 Cr., marking an increase of 0.15 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.27 Cr.. The value appears to be declining and may need further review. It has decreased from 96.20 Cr. (Mar 2025) to 0.27 Cr., marking a decrease of 95.93 Cr..
• For Tax %, as of Jun 2025, the value is 14.81%. The value appears to be improving (decreasing) as expected. It has decreased from 25.67% (Mar 2025) to 14.81%, marking a decrease of 10.86%.
• For Net Profit, as of Jun 2025, the value is 0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 71.51 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 71.29 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.16. The value appears to be declining and may need further review. It has decreased from 50.75 (Mar 2025) to 0.16, marking a decrease of 50.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:56 am

Growth

Last Updated: September 5, 2025, 10:10 am

Balance Sheet

Last Updated: September 10, 2025, 2:00 pm

Below is a detailed analysis of the balance sheet data for Magadh Sugar & Energy Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 820.00 Cr.. The value appears strong and on an upward trend. It has increased from 732.00 Cr. (Mar 2024) to 820.00 Cr., marking an increase of 88.00 Cr..
• For Borrowings, as of Mar 2025, the value is 707.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 637.00 Cr. (Mar 2024) to 707.00 Cr., marking an increase of 70.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 148.00 Cr.. The value appears to be improving (decreasing). It has decreased from 228.00 Cr. (Mar 2024) to 148.00 Cr., marking a decrease of 80.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,689.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,611.00 Cr. (Mar 2024) to 1,689.00 Cr., marking an increase of 78.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 896.00 Cr.. The value appears strong and on an upward trend. It has increased from 792.00 Cr. (Mar 2024) to 896.00 Cr., marking an increase of 104.00 Cr..
• For CWIP, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 35.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 753.00 Cr.. The value appears to be declining and may need further review. It has decreased from 815.00 Cr. (Mar 2024) to 753.00 Cr., marking a decrease of 62.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,689.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,611.00 Cr. (Mar 2024) to 1,689.00 Cr., marking an increase of 78.00 Cr..

Notably, the Reserves (820.00 Cr.) exceed the Borrowings (707.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Magadh Sugar & Energy Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 77.67. This value is within the healthy range. It has decreased from 82.61 (Mar 24) to 77.67, marking a decrease of 4.94.
• For Diluted EPS (Rs.), as of Mar 25, the value is 77.67. This value is within the healthy range. It has decreased from 82.61 (Mar 24) to 77.67, marking a decrease of 4.94.
• For Cash EPS (Rs.), as of Mar 25, the value is 97.13. This value is within the healthy range. It has decreased from 100.65 (Mar 24) to 97.13, marking a decrease of 3.52.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 591.81. It has increased from 529.11 (Mar 24) to 591.81, marking an increase of 62.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 591.81. It has increased from 529.11 (Mar 24) to 591.81, marking an increase of 62.70.
• For Dividend / Share (Rs.), as of Mar 25, the value is 12.50. This value exceeds the healthy maximum of 3. It has decreased from 15.00 (Mar 24) to 12.50, marking a decrease of 2.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 938.35. It has increased from 778.18 (Mar 24) to 938.35, marking an increase of 160.17.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 151.63. This value is within the healthy range. It has decreased from 152.31 (Mar 24) to 151.63, marking a decrease of 0.68.
• For PBIT / Share (Rs.), as of Mar 25, the value is 132.17. This value is within the healthy range. It has decreased from 134.27 (Mar 24) to 132.17, marking a decrease of 2.10.
• For PBT / Share (Rs.), as of Mar 25, the value is 104.87. This value is within the healthy range. It has decreased from 111.12 (Mar 24) to 104.87, marking a decrease of 6.25.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 77.67. This value is within the healthy range. It has decreased from 82.61 (Mar 24) to 77.67, marking a decrease of 4.94.
• For PBDIT Margin (%), as of Mar 25, the value is 16.15. This value is within the healthy range. It has decreased from 19.57 (Mar 24) to 16.15, marking a decrease of 3.42.
• For PBIT Margin (%), as of Mar 25, the value is 14.08. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 14.08, marking a decrease of 3.17.
• For PBT Margin (%), as of Mar 25, the value is 11.17. This value is within the healthy range. It has decreased from 14.28 (Mar 24) to 11.17, marking a decrease of 3.11.
• For Net Profit Margin (%), as of Mar 25, the value is 8.27. This value is within the healthy range. It has decreased from 10.61 (Mar 24) to 8.27, marking a decrease of 2.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.12. This value is below the healthy minimum of 15. It has decreased from 15.61 (Mar 24) to 13.12, marking a decrease of 2.49.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.46. This value is within the healthy range. It has decreased from 21.76 (Mar 24) to 17.46, marking a decrease of 4.30.
• For Return On Assets (%), as of Mar 25, the value is 6.47. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 6.47, marking a decrease of 0.75.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.09 (Mar 24) to 0.20, marking an increase of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.84. This value is within the healthy range. It has decreased from 0.85 (Mar 24) to 0.84, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has increased from 0.72 (Mar 24) to 0.80, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.19, marking an increase of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 4. It has increased from 1.37 (Mar 24) to 1.82, marking an increase of 0.45.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.31. This value is below the healthy minimum of 20. It has increased from 8.47 (Mar 24) to 19.31, marking an increase of 10.84.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.44. This value is below the healthy minimum of 20. It has increased from 6.95 (Mar 24) to 15.44, marking an increase of 8.49.
• For Earning Retention Ratio (%), as of Mar 25, the value is 80.69. This value exceeds the healthy maximum of 70. It has decreased from 91.53 (Mar 24) to 80.69, marking a decrease of 10.84.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.56. This value exceeds the healthy maximum of 70. It has decreased from 93.05 (Mar 24) to 84.56, marking a decrease of 8.49.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.55. This value is within the healthy range. It has decreased from 6.58 (Mar 24) to 5.55, marking a decrease of 1.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.85. This value is within the healthy range. It has decreased from 4.57 (Mar 24) to 3.85, marking a decrease of 0.72.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,551.50. It has increased from 1,389.56 (Mar 24) to 1,551.50, marking an increase of 161.94.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.27 (Mar 24) to 1.17, marking a decrease of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 7.26. This value is within the healthy range. It has increased from 6.47 (Mar 24) to 7.26, marking an increase of 0.79.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to 0.63, marking a decrease of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 80.68. This value exceeds the healthy maximum of 70. It has decreased from 91.52 (Mar 24) to 80.68, marking a decrease of 10.84.
• For Price / BV (X), as of Mar 25, the value is 1.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to 0.63, marking a decrease of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has decreased from 0.15 (Mar 24) to 0.12, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness